New Delhi:Shares of Sun Pharmaceutical Industries on Friday tumbled nearly 6 per cent after the company reported a 20 per cent year-on-year decline in consolidated net profit for the first quarter ended June 30, 2025.Extending its previous day's decline, the company's stock tanked 5.70 per cent to Rs 1,608.30 on the BSE.
At the NSE, it dropped 5.78 per cent to Rs 1,608.Shares of Sun Pharmaceutical Industries had on Thursday fell by nearly 2 per cent.Sun Pharmaceutical Industries on Thursday reported a 20 per cent year-on-year decline in consolidated net profit to Rs 2,279 crore for the first quarter ended June 30, 2025.
National Payments Corporation Of India Set To Implement Changes To The Unified Payments Interface From August 1, 2025The Mumbai-based drug major posted a net profit of Rs 2,836 crore for the April-June quarter of the last financial year.Adjusted net profit, excluding the exceptional items, for the first quarter stood at Rs 2,996 crore, up 6 per cent year-on-year.Total income rose to 14,316 crore for the June quarter against Rs 13,185 crore in the year-ago period, Sun Pharma said in a regulatory filing.
Disclaimer: This story is from the syndicated feed. Nothing has changed except the headline.
You may also like
Son Heung-min leaves pitch in tears after final Tottenham appearance against Newcastle
Srinagar airport ruckus: Army officer assaults SpiceJet staff over baggage fee; Army says 'committed to discipline, cooperating with probe'
Kolkata shocker: Man dies by suicide fearing deportation to Bangladesh over NRC; family says he fled Dhaka in 1972, had all papers
RS MP Gulam Ali Khatana slams Pak, lauds security forces for counter-terror ops in J&K
Hungarian Grand Prix result as F1 race ends in thrilling Lando Norris and Oscar Piastri duel